Abstract
The first cases of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 or COVID-19) infections were recorded in China in November 2019. Since its appearance in China at the end of last year, the virus has spread to all continents causing a "global pandemic". To date, some aspects remain to be investigate about the pathophysiology of this viral infection. One of the aspects to be still clarified is the correlation between the renin-angiotensin system (RAS) and SARS-CoV-2 infection. RAS is a physiological system playing a key role in different human body functions regulation. SARS-CoV-2 uses the angiotensin-converting enzyme 2 (ACE-2), a component of RAS, as a potential factor of cell penetration and infectivity; in addition, in the different infection stages, a functional variation of the RAS has been noted. In this article, we discuss the correlation between the role of RAS and system-modifying agents, angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor blockers (ARBs) and direct renin inhibitors (DRIs), with SARS-CoV-2 infection.
References
Jul 12, 2002·Journal of Neuroscience Research·Yong B LeeSeung U Kim
May 18, 2005·Circulation·Carlos M FerrarioPatricia E Gallagher
Jul 8, 2005·Nature·Yumiko ImaiJosef M Penninger
Nov 18, 2006·Atherosclerosis·Adrian RecinosAllan R Brasier
Nov 22, 2007·Journal of Managed Care Pharmacy : JMCP·Steven A Atlas
Nov 21, 2007·Molecular Medicine·Rodrigo Araújo Fraga-SilvaRobson Augusto Souza Santos
Jul 27, 2011·Clinics·Rodrigo Araujo Fraga-SilvaRobson A S Santos
Oct 8, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Suguru YamamotoValentina Kon
Feb 7, 2013·Blood·Chao FangAlvin H Schmaier
Jul 31, 2013·The Journal of Surgical Research·Qiuhua ChenHaibo Qiu
Oct 31, 2013·American Journal of Respiratory Cell and Molecular Biology·Ying MengXu Li
Jan 7, 2015·British Journal of Pharmacology·G S MagalhãesM J Campagnole-Santos
Oct 26, 2016·Progress in Cardiovascular Diseases·Chirag BavishiFranz H Messerli
Jan 30, 2018·Frontiers in Physiology·Wan-Yu PaiHuang-Joe Wang
Apr 3, 2019·Journal of Cardiovascular Development and Disease·Ali NehmeKazem Zibara
Jan 28, 2020·Lancet·Chaolin HuangBin Cao
Feb 6, 2020·Nature·Peng ZhouZheng-Li Shi
Feb 9, 2020·Virologica Sinica·Yuntao Wu
Mar 4, 2020·Intensive Care Medicine·Haibo ZhangArthur S Slutsky
Mar 7, 2020·Nature Reviews. Cardiology·Ying-Ying ZhengXiang Xie
Mar 15, 2020·The Lancet. Respiratory Medicine·Lei FangMichael Roth
Mar 21, 2020·European Heart Journal·Gabriela M KusterStefan Osswald
Apr 1, 2020·The New England Journal of Medicine·Muthiah VaduganathanScott D Solomon
Apr 4, 2020·JAMA Cardiology·Chirag BavishiFranz H Messerli
Citations
Sep 3, 2020·SN Comprehensive Clinical Medicine·Antonio VitielloFrancesco Ferrara
Jan 15, 2021·Naunyn-Schmiedeberg's Archives of Pharmacology·Francesco Ferrara, Antonio Vitiello
Sep 30, 2020·Life Sciences·A Vitiello, F Ferrara
Feb 8, 2021·Respiratory Medicine·Antonio Vitiello, Francesco Ferrara
Nov 19, 2020·Irish Journal of Medical Science·Antonio Vitiello, Francesco Ferrara
Dec 4, 2020·BMJ Evidence-based Medicine·Antonio VitielloFrancesco Ferrara
Jan 19, 2021·Medical Hypotheses·Antonio VitielloFrancesco Ferrara
Mar 30, 2021·Wiener klinische Wochenschrift·Francesco Ferrara, Antonio Vitiello
Apr 10, 2021·Cardiovascular Toxicology·F Ferrara, A Vitiello
Apr 21, 2021·Wiener klinische Wochenschrift·Antonio Vitiello, Francesco Ferrara
May 2, 2021·Inflammopharmacology·Antonio Vitiello, Francesco Ferrara
Nov 6, 2021·Immunologic Research·Antonio Vitiello, Francesco Ferrara